Mission Therapeutics receives $500k grant for Parkinson’s research
Mission Therapeutics was granted $500,000 from the The Michael J Fox Foundation for Parkinson’s Research for DUB inhibitor testing.
List view / Grid view
Mission Therapeutics was granted $500,000 from the The Michael J Fox Foundation for Parkinson’s Research for DUB inhibitor testing.
25 May 2016 | By Victoria White, Digital Content Producer
MJFF is to fund two projects leveraging the promise of engineered stem cells to speed new therapies and deeper understanding of Parkinson's disease...
3 May 2016 | By Victoria White, Digital Content Producer
Oral administration of a Jakinib lessened the destructive inflammation and nerve cell degradation in the area of the brain affected by Parkinson's...
5 May 2015 | By Victoria White
MJFF and Prothena have teamed up to accelerate the discovery of novel biomarkers and development of assays to measure Parkinson's disease progression...